Studying a drug to preserve muscle in older hip fracture patients
Treatments studied
Part of Bones, joints & muscles, Injuries & trauma clinical trials.
This trial tests a drug that may help older people who break a hip and have low muscle mass (sarcopenia). It aims to see if the drug can help preserve muscle strength and speed up recovery after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have a broken hip from a fall or similar low-impact injury, and you are having surgery.
- You have sarcopenia, meaning low muscle mass plus low grip strength or slow walking speed.
- You have not recently taken osteoporosis medication.
- You do not have serious health issues like advanced kidney disease, active cancer, or severe dementia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called Denosumab, which is used to treat bone loss, can also help improve muscle strength and mass in older adults who have both osteoporosis and sarcopenia. If you qualify, you would receive the drug and be monitored over time to see if it helps your bones and muscles.
This study tests an investigational drug called Isomyosamine, which aims to reduce inflammation and prevent muscle loss after a hip or thigh fracture. It is designed for older adults who are at risk for frailty or sarcopenia after their injury.
This study looks at how muscle loss (sarcopenia) affects recovery after a hip fracture, comparing people of normal weight and those with obesity. It may help find better ways to support recovery.
This trial looks at how muscle health affects your ability to get back to normal activities after hip replacement surgery for a broken hip or severe arthritis. By using MRI scans and other tests, researchers hope to understand if having less muscle makes recovery harder.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This study looks at ways to prevent bone thinning (osteoporosis) and muscle loss (sarcopenia) in middle-aged adults. It includes exercise and healthy eating programs, which may also help with existing conditions like high blood pressure or diabetes.
Hear when a new Sarcopenia in Elderly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.